The company operates as a non-banking financial company focused on lending and investments, while its primary subsidiary, Maximus International, manufactures and distributes lubricants and petrochemical products across India, the UAE, and Kenya.
The company lacks a durable moat as its primary earnings driver is the distribution and manufacturing of lubricants, a highly competitive and commodity-like industry. While revenue growth is high, net margins are thin at 4.4%, suggesting a lack of pricing power or unique cost advantages.
Management has focused on expanding its lubricant manufacturing footprint in East Africa and the UAE. While revenue has scaled significantly, the negative cash conversion suggests that growth is being funded by working capital absorption rather than free cash flow.
The company's aggressive expansion into the commodity lubricant market eventually hit a wall as working capital requirements outpaced its ability to generate actual cash. The negative cash conversion cycle, which was visible years prior, finally forced a liquidity crisis when credit markets tightened. As margins remained razor-thin due to a lack of pricing power, the high volume of inter-corporate deposits and related-party loans created a contagion effect within the group, leading to a collapse in shareholder confidence and a permanent re-rating of the stock as a low-quality financial shell rather than a growth business.
RichFakir rates Optimus Finance Ltd's business quality as poor — 32/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Optimus Finance Ltd is trading about 35% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Optimus Finance Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Optimus Finance Ltd's fair value is about ₹18 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →